Experimental cancer drug trial halted early
Disease control
Terminated
This early-stage trial tested a new drug called EO-3021 in adults with advanced solid tumors, especially stomach cancer, that have a specific marker (CLDN18.2). The study aimed to find safe doses and check for side effects, but it was terminated early. About 88 people were expect…
Phase: PHASE1 • Sponsor: Elevation Oncology • Aim: Disease control
Last updated May 08, 2026 12:04 UTC